646 related articles for article (PubMed ID: 21727056)
1. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
Sarifakioglu E; Onur O; Kart H; Yilmaz AE
Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
[No Abstract] [Full Text] [Related]
2. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
3. Acne fulminans following isotretinoin therapy.
Didona D; Paolino G; Cantisani C; Viti G; Caposiena Caro DR; Didona B
G Ital Dermatol Venereol; 2019 Feb; 154(1):84-85. PubMed ID: 28712269
[No Abstract] [Full Text] [Related]
4. [Acne fulminans triggered by isotretinoin therapy].
Joly P; Prost C; Gaudemar M; Revuz J
Ann Dermatol Venereol; 1991; 118(5):369-72. PubMed ID: 1832826
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
6. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
Kaymak Y; Ilter N
Dermatol Nurs; 2006 Dec; 18(6):576-80. PubMed ID: 17286159
[No Abstract] [Full Text] [Related]
7. Pseudo-acne fulminans associated with oral isotretinoin.
Grando LR; Leite OG; Cestari TF
An Bras Dermatol; 2014; 89(4):657-9. PubMed ID: 25054758
[TBL] [Abstract][Full Text] [Related]
8. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
9. Acne fulminans and isotretinoin: case report.
Pereira MF; Roncada EM; Oliveira CM; Monteiro R; Abreu MA; Ortigosa LC
An Bras Dermatol; 2011; 86(5):983-5. PubMed ID: 22147039
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin updates.
On SC; Zeichner J
Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
[TBL] [Abstract][Full Text] [Related]
11. Acne fulminans induced by a low dose isotretinoin: case report and review of the literature.
Fakih A; Goens J; Grozdev I; Dangoisse C; Richert B
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423422
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence.
Gualtieri B; Panduri S; Chiricozzi A; Romanelli M
G Ital Dermatol Venereol; 2020 Jun; 155(3):361-362. PubMed ID: 30229637
[No Abstract] [Full Text] [Related]
13. On isotretinoin dosing, adverse effects, and efficacy.
Berk DR
Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
[No Abstract] [Full Text] [Related]
14. Myths of isotretinoin therapy in patients with acne: a personal opinion.
Alcalay J
J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
[TBL] [Abstract][Full Text] [Related]
15. Creatine phosphokinase values during isotretinoin treatment for acne.
Kaymak Y
Int J Dermatol; 2008 Apr; 47(4):398-401. PubMed ID: 18377609
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
17. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
18. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
[No Abstract] [Full Text] [Related]
19. Isotretinoin-induced skin fragility in a teenaged athlete: a case report.
Pavlis MB; Lieblich L
Cutis; 2013 Jul; 92(1):33-4. PubMed ID: 23961523
[TBL] [Abstract][Full Text] [Related]
20. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
Mostow EN
Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
